Viral subversion of the nuclear pore complex

Viruses

Volumn 5, Issue 8, 2013, Pages 2019-2042

  Le Sage, Valerie ^a,b   Mouland, Andrew J ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Nuclear pore complex; Nucleocytoplasmic transport; Nucleoporins; Viruses

Indexed keywords

NUCLEOPORIN;

ADENOVIRUS; CARDIOVIRUS; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENE PRODUCT; GENE REPLICATION; GENETIC TRANSCRIPTION; HEPADNAVIRUS; HEPATITIS B VIRUS; HERPES SIMPLEX VIRUS 1; HERPES VIRUS; HOST RESISTANCE; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLUENZA VIRUS A; LIFE CYCLE; NONHUMAN; NUCLEAR PORE COMPLEX; ORTHOMYXOVIRUS; PICORNAVIRUS; POLIOMYELITIS VIRUS; RETROVIRUS; REVIEW; RHABDOVIRUS; RHINOVIRUS; VESICULAR STOMATITIS VIRUS; VIRUS ENTRY; VIRUS GENOME; VIRUS INFECTION; VIRUS PARTICLE;

CELL NUCLEUS; CYTOPLASM; HUMANS; NUCLEAR PORE; RNA, VIRAL; VIRAL PROTEINS; VIRUS PHYSIOLOGICAL PHENOMENA; VIRUS REPLICATION;

EID: 84882725999     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v5082019     Document Type: Review

References (144)

1. Kramer, A.; Ludwig, Y.; Shahin, V.; Oberleithner, H. A pathway separate from the central channel through the nuclear pore complex for inorganic ions and small macromolecules. J. Biol. Chem. 2007, 282, 31437-31443.
2. Mohr, D.; Frey, S.; Fischer, T.; Guttler, T.; Gorlich, D. Characterisation of the passive permeability barrier of nuclear pore complexes. EMBO J. 2009, 28, 2541-2553.
3. Pante, N.; Kann, M. Nuclear pore complex is able to transport macromolecules with diameters of about 39 nm. Mol. Biol. Cell 2002, 13, 425-434.
4. Cronshaw, J.M.; Krutchinsky, A.N.; Zhang, W.; Chait, B.T.; Matunis, M.J. Proteomic analysis of the mammalian nuclear pore complex. J. Cell Biol. 2002, 158, 915-927.
5. Alber, F.; Dokudovskaya, S.; Veenhoff, L.M.; Zhang, W.; Kipper, J.; Devos, D.; Suprapto, A.; Karni-Schmidt, O.; Williams, R.; Chait, B. T.; et al. Determining the architectures of macromolecular assemblies. Nature 2007, 450, 683-694.
6. Alber, F.; Dokudovskaya, S.; Veenhoff, L.M.; Zhang, W.; Kipper, J.; Devos, D.; Suprapto, A.; Karni-Schmidt, O.; Williams, R.; Chait, B. T.; et al. The molecular architecture of the nuclear pore complex. Nature 2007, 450, 695-701.
7. Hoelz, A.; Debler, E.W.; Blobel, G. The structure of the nuclear pore complex. Annu. Rev. Biochem. 2011, 80, 613-643.
8. Kopito, R.B.; Elbaum, M. Reversibility in nucleocytoplasmic transport. Proc. Natl. Acad. Sci. USA 2007, 104, 12743-12748.
9. Wente, S.R.; Rout, M.P. The nuclear pore complex and nuclear transport. Cold Spring Harb. Perspect. Biol. 2010, 2, a000562.
10. Cohen, S.; Au, S.; Pante, N. How viruses access the nucleus. Biochim. Biophys. Acta 2011, 1813, 1634-1645.
11. Cohen, S.; Etingove, I.; Panté, N. Effect of viral infection on the nuclear envelope and nuclear pore complex. Int. Rev. Cell Mol. Biol. 2012, 117-159.
12. Kobiler, O.; Drayman, N.; Butin-Israeli, V.; Oppenheim, A. Virus strategies for passing the nuclear envelope barrier. Nucleus 2012, 3, 526-539.
13. Saphire, A.C.; Guan, T.; Schirmer, E.C.; Nemerow, G.R.; Gerace, L. Nuclear import of adenovirus DNA in vitro involves the nuclear protein import pathway and hsc70. J. Biol. Chem. 2000,275, 4298-4304.
14. Strunze, S.; Trotman, L.C.; Boucke, K.; Greber, U.F. Nuclear targeting of adenovirus type 2 requires Crm1-mediated nuclear export. Mol. Biol. Cell 2005, 16, 2999-3009.
15. Strunze, S.; Engelke, M.F.; Wang, I.H.; Puntener, D.; Boucke, K.; Schleich, S.; Way, M.; Schoenenberger, P.; Burckhardt, C.J.; Greber, U.F. Kinesin-1-mediated capsid disassembly and disruption of the nuclear pore complex promote virus infection. Cell Host Microbe 2011, 10, 210-223.
16. Trotman, L.C.; Mosberger, N.; Fornerod, M.; Stidwill, R.P.; Greber, U.F. Import of adenovirus DNA involves the nuclear pore complex receptor Can/Nup214 and histone H1. Nat. Cell Biol 2001, 3, 1092-1100.
17. Hindley, C.E.; Lawrence, F.J.; Matthews, D.A. A role for transportin in the nuclear import of adenovirus core proteins and DNA. Traffic 2007, 8, 1313-1322.
18. Yatherajam, G.; Huang, W.; Flint, S.J. Export of adenoviral late mRNA from the nucleus requires the Nxf1/Tap export receptor. J. Virol. 2011, 85, 1429-1438.
19. Ojala, P.M.; Sodeik, B.; Ebersold, M.W.; Kutay, U.; Helenius, A. Herpes simplex virus type 1 entry into host cells: Reconstitution of capsid binding and uncoating at the nuclear pore complex in vitro. Mol. Cell Biol. 2000, 20, 4922-4931.
20. Pasdeloup, D.; Blondel, D.; Isidro, A.L.; Rixon, F.J. Herpesvirus capsid association with the nuclear pore complex and viral DNA release involve the nucleoporin Can/Nup214 and the capsid protein pUL25. J. Virol. 2009, 83, 6610-6623.
21. Copeland, A.M.; Newcomb, W.W.; Brown, J.C. Herpes simplex virus replication: Roles of viral proteins and nucleoporins in capsid-nucleus attachment. J. Virol. 2009, 83, 1660-1668.
22. Johnson, L.A.; Li, L.; Sandri-Goldin, R.M. The cellular RNA export receptor TAP/NXF1 is required for ICP27-mediated export of herpes simplex virus 1 RNA, but the TREX complex adaptor protein Aly/REF appears to be dispensable. J. Virol. 2009, 83, 6335-6346.
23. Malik, P.; Tabarraei, A.; Kehlenbach, R.H.; Korfali, N.; Iwasawa, R.; Graham, S.V.; Schirmer, E.C. Herpes simplex virus ICP27 protein directly interacts with the nuclear pore complex through NUP62, inhibiting host nucleocytoplasmic transport pathways. J. Biol. Chem. 2012, 287, 12277-12292.
24. Ray, N.; Enquist, L.W. Transcriptional response of a common permissive cell type to infection by two diverse alphaherpesviruses. J. Virol. 2004, 78, 3489-3501.
25. Chang, C.W.; Lee, C.P.; Huang, Y.H.; Yang, P.W.; Wang, J.T.; Chen, M.R. Epstein-barr virus protein kinase BGLF4 targets the nucleus through interaction with nucleoporins. J. Virol. 2012, 86, 8072-8085.
26. Gustin, K.E.; Sarnow, P. Effects of poliovirus infection on nucleo-cytoplasmic trafficking and nuclear pore complex composition. EMBO J. 2001, 20, 240-249.
27. Gustin, K.E.; Sarnow, P. Inhibition of nuclear import and alteration of nuclear pore complex composition by rhinovirus. J. Virol. 2002, 76, 8787-8796.
28. Park, N.; Katikaneni, P.; Skern, T.; Gustin, K.E. Differential targeting of nuclear pore complex proteins in poliovirus-infected cells. J. Virol. 2008, 82, 1647-1655.
29. Porter, F.W.; Palmenberg, A.C. Leader-induced phosphorylation of nucleoporins correlates with nuclear trafficking inhibition by cardioviruses. J. Virol. 2009, 83, 1941-1951.
30. Ricour, C.; Delhaye, S.; Hato, S.V.; Olenyik, T.D.; Michel, B.; van Kuppeveld, F.J.; Gustin, K.E.; Michiels, T. Inhibition of mRNA export and dimerization of interferon regulatory factor 3 by theiler's virus leader protein. J. Gen. Virol. 2009, 90, 177-186.
31. Gabriel, G.; Herwig, A.; Klenk, H.D. Interaction of polymerase subunit PB2 and NP with importin α1 is a determinant of host range of influenza a virus. PLoS Pathog. 2008, 4, e11.
32. Sasaki, Y.; Hagiwara, K.; Kakisaka, M.; Yamada, K.; Murakami, T.; Aida, Y. Importin α3/Qip1 is involved in multiplication of mutant influenza virus with alanine mutation at amino acid 9 independently of nuclear transport function. PLoS One 2013, 8, e55765.
33. Tarendeau, F.; Boudet, J.; Guilligay, D.; Mas, P.J.; Bougault, C.M.; Boulo, S.; Baudin, F.; Ruigrok, R.W.; Daigle, N.; Ellenberg, J.; et al. Structure and nuclear import function of the C-terminal domain of influenza virus polymerase pb2 subunit. Nat. Struct. Mol. Biol. 2007, 14, 229-233.
34. Karlas, A.; Machuy, N.; Shin, Y.; Pleissner, K.P.; Artarini, A.; Heuer, D.; Becker, D.; Khalil, H.; Ogilvie, L.A.; Hess, S.; et al. Genome-wide rnai screen identifies human host factors crucial for influenza virus replication. Nature 2010, 463, 818-822.
35. Konig, R.; Stertz, S.; Zhou, Y.; Inoue, A.; Hoffmann, H.H.; Bhattacharyya, S.; Alamares, J.G.; Tscherne, D.M.; Ortigoza, M.B.; Liang, Y.; et al. Human host factors required for influenza virus replication. Nature 2010, 463, 813-817.
36. Elton, D.; Simpson-Holley, M.; Archer, K.; Medcalf, L.; Hallam, R.; McCauley, J.; Digard, P. Interaction of the influenza virus nucleoprotein with the cellular Crm1-mediated nuclear export pathway. J. Virol. 2001, 75, 408-419.
37. Watanabe, K.; Takizawa, N.; Katoh, M.; Hoshida, K.; Kobayashi, N.; Nagata, K. Inhibition of nuclear export of ribonucleoprotein complexes of influenza virus by leptomycin B. Virus Res. 2001, 77, 31-42.
38. Morita, M.; Kuba, K.; Ichikawa, A.; Nakayama, M.; Katahira, J.; Iwamoto, R.; Watanebe, T.; Sakabe, S.; Daidoji, T.; Nakamura, S.; et al. The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza. Cell 2013, 153, 112-125.
39. Satterly, N.; Tsai, P.L.; van Deursen, J.; Nussenzveig, D.R.; Wang, Y.; Faria, P.A.; Levay, A.; Levy, D.E.; Fontoura, B.M. Influenza virus targets the mrna export machinery and the nuclear pore complex. Proc. Natl. Acad. Sci. USA 2007, 104, 1853-1858.
40. Hao, L.; Sakurai, A.; Watanabe, T.; Sorensen, E.; Nidom, C.A.; Newton, M.A.; Ahlquist, P.; Kawaoka, Y. Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature 2008, 454, 890-893.
41. Chen, J.; Huang, S.; Chen, Z. Human cellular protein nucleoporin hNup98 interacts with influenza A virus NS2/nuclear export protein and overexpression of its GLFG repeat domain can inhibit virus propagation. J. Gen. Virol. 2010, 91, 2474-2484.
42. Von Kobbe, C.; van Deursen, J.M.; Rodrigues, J.P.; Sitterlin, D.; Bachi, A.; Wu, X.; Wilm, M.; Carmo-Fonseca, M.; Izaurralde, E. Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleoporin Nup98. Mol. Cell 2000, 6, 1243-1252.
43. Faria, P.A.; Chakraborty, P.; Levay, A.; Barber, G.N.; Ezelle, H.J.; Enninga, J.; Arana, C.; van Deursen, J.; Fontoura, B.M. VSV disrupts the Rae1/mrnp41 mRNA nuclear export pathway. Mol. Cell 2005, 17, 93-102.
44. Di Nunzio, F.; Danckaert, A.; Fricke, T.; Perez, P.; Fernandez, J.; Perret, E.; Roux, P.; Shorte, S.; Charneau, P.; Diaz-Griffero, F.; et al. Human nucleoporins promote HIV-1 docking at the nuclear pore, nuclear import and integration. PLoS One 2012, 7, e46037.
45. Di Nunzio, F.; Fricke, T.; Miccio, A.; Valle-Casuso, J.C.; Perez, P.; Souque, P.; Rizzi, E.; Severgnini, M.; Mavilio, F.; Charneau, P.; et al. Nup153 and Nup98 bind the HIV-1 core and contribute to the early steps of HIV-1 replication. Virology 2013, 440, 8-18.
46. Konig, R.; Zhou, Y.; Elleder, D.; Diamond, T.L.; Bonamy, G.M.; Irelan, J.T.; Chiang, C.Y.; Tu, B.P.; de Jesus, P.D.; Lilley, C. E.; et al. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 2008, 135, 49-60.
47. Brass, A.L.; Dykxhoorn, D.M.; Benita, Y.; Yan, N.; Engelman, A.; Xavier, R.J.; Lieberman, J.; Elledge, S.J. Identification of host proteins required for HIV infection through a functional genomic screen. Science 2008, 319, 921-926.
48. Lee, K.; Ambrose, Z.; Martin, T.D.; Oztop, I.; Mulky, A.; Julias, J.G.; Vandegraaff, N.; Baumann, J.G.; Wang, R.; Yuen, W.; et al. Flexible use of nuclear import pathways by HIV-1. Cell Host Microbe 2010, 7, 221-233.
49. Zhou, H.; Xu, M.; Huang, Q.; Gates, A.T.; Zhang, X.D.; Castle, J.C.; Stec, E.; Ferrer, M.; Strulovici, B.; Hazuda, D. J.; et al. Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 2008, 4, 495-504.
50. Bogerd, H.P.; Echarri, A.; Ross, T.M.; Cullen, B.R. Inhibition of human immunodeficiency virus Rev and human T-cell leukemia virus Rex function, but not Mason-Pfizer monkey virus constitutive transport element activity, by a mutant human nucleoporin targeted to Crm1. J. Virol. 1998, 72, 8627-8635.
51. Krishnan, L.; Matreyek, K.A.; Oztop, I.; Lee, K.; Tipper, C.H.; Li, X.; Dar, M.J.; Kewalramani, V.N.; Engelman, A. The requirement for cellular transportin 3 (TNPO3 or TRN-SR2) during infection maps to human immunodeficiency virus type 1 capsid and not integrase. J. Virol. 2010, 84, 397-406.
52. Imbeault, M.; Ouellet, M.; Tremblay, M.J. Microarray study reveals that HIV-1 induces rapid type 1 interferon-dependent p53 mRNA up-regulation in human primary CD4+ T cells. Retrovirology 2009, 6, doi:10.1186/1742-4690-6-5.
53. Ao, Z.; Jayappa, K.D.; Wang, B.; Zheng, Y.; Wang, X.; Peng, J.; Yao, X. Contribution of host nucleoporin 62 in HIV-1 integrase chromatin association and viral DNA integration. J. Biol. Chem. 2012, 287, 10544-10555.
54. Monette, A.; Pante, N.; Mouland, A.J. HIV-1 remodels the nuclear pore complex. J. Cell Biol. 2011, 193, 619-631.
55. Schmitz, A.; Schwarz, A.; Foss, M.; Zhou, L.; Rabe, B.; Hoellenriegel, J.; Stoeber, M.; Pante, N.; Kann, M. Nucleoporin 153 arrests the nuclear import of hepatitis B virus capsids in the nuclear basket. PLoS Pathog. 2010, 6, e1000741.
56. Tomko, R.P.; Xu, R.; Philipson, L. Hcar and mcar: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc. Natl. Acad. Sci. USA 1997, 94, 3352-3356.
57. Puntener, D.; Engelke, M.F.; Ruzsics, Z.; Strunze, S.; Wilhelm, C.; Greber, U.F. Stepwise loss of fluorescent core protein V from human adenovirus during entry into cells. J. Virol. 2011, 85, 481-496.
58. Scherer, J.; Vallee, R.B. Adenovirus recruits dynein by an evolutionary novel mechanism involving direct binding to pH-primed hexon. Viruses 2011, 3, 1417-1431.
59. Suomalainen, M.; Greber, U. F. Uncoating of non-enveloped viruses. Curr. Opin. Virol. 2013, 3, 27-33.
60. Wolff, B.; Sanglier, J.J.; Wang, Y. Leptomycin B is an inhibitor of nuclear export: Inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA. Chem. Biol. 1997, 4, 139-147.
61. Xue, Y.; Johnson, J.S.; Ornelles, D.A.; Lieberman, J.; Engel, D.A. Adenovirus protein VII functions throughout early phase and interacts with cellular proteins set and pp32. J. Virol. 2005, 79, 2474-2483.
62. Schmid, M.; Gonzalez, R.A.; Dobner, T. Crm1-dependent transport supports cytoplasmic accumulation of adenoviral early transcripts. J. Virol. 2012, 86, 2282-2292.
63. Roizman, B.; Knipe, D.M. Herpes simplex viruses and their replication. In Fields Virology, 4th ed.; Knipe, D.M., Ed.; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2001.
64. Heldwein, E.E.; Krummenacher, C. Entry of herpesviruses into mammalian cells. Cell Mol. Life Sci. 2008, 65, 1653-1668.
65. Radtke, K.; Kieneke, D.; Wolfstein, A.; Michael, K.; Steffen, W.; Scholz, T.; Karger, A.; Sodeik, B. Plus-and minus-end directed microtubule motors bind simultaneously to herpes simplex virus capsids using different inner tegument structures. PLoS Pathog. 2010, 6, e1000991.
66. Liashkovich, I.; Hafezi, W.; Kuhn, J.M.; Oberleithner, H.; Shahin, V. Nuclear delivery mechanism of herpes simplex virus type 1 genome. J. Mol. Recognit. 2011, 24, 414-421.
67. Abaitua, F.; Hollinshead, M.; Bolstad, M.; Crump, C.M.; O'Hare, P. A nuclear localization signal in herpesvirus protein VP1-2 is essential for infection via capsid routing to the nuclear pore. J. Virol. 2012, 86, 8998-9014.
68. Jovasevic, V.; Liang, L.; Roizman, B. Proteolytic cleavage of VP1-2 is required for release of herpes simplex virus 1 DNA into the nucleus. J. Virol. 2008, 82, 3311-3319.
69. Preston, V.G.; Murray, J.; Preston, C.M.; McDougall, I.M.; Stow, N.D. The UL25 gene product of herpes simplex virus type 1 is involved in uncoating of the viral genome. J. Virol. 2008, 82, 6654-6666.
70. Leuzinger, H.; Ziegler, U.; Schraner, E.M.; Fraefel, C.; Glauser, D.L.; Heid, I.; Ackermann, M.; Mueller, M.; Wild, P. Herpes simplex virus 1 envelopment follows two diverse pathways. J. Virol. 2005, 79, 13047-13059.
71. Moroianu, J.; Blobel, G.; Radu, A. Rangtp-mediated nuclear export of karyopherin alpha involves its interaction with the nucleoporin Nup153. Proc. Natl. Acad. Sci. USA 1997, 94, 9699-9704.
72. Lee, C.P.; Chen, M.R. Escape of herpesviruses from the nucleus. Rev. Med. Virol. 2010, 20, 214-230.
73. Wild, P.; Senn, C.; Manera, C.L.; Sutter, E.; Schraner, E.M.; Tobler, K.; Ackermann, M.; Ziegler, U.; Lucas, M.S.; Kaech, A. Exploring the nuclear envelope of herpes simplex virus 1-infected cells by high-resolution microscopy. J. Virol. 2009, 83, 408-419.
74. Castello, A.; Alvarez, E.; Carrasco, L. The multifaceted poliovirus 2A protease: Regulation of gene expression by picornavirus proteases. J. Biomed. Biotechnol. 2011, e369648.
75. Waggoner, S.; Sarnow, P. Viral ribonucleoprotein complex formation and nucleolar-cytoplasmic relocalization of nucleolin in poliovirus-infected cells. J. Virol. 1998, 72, 6699-6709.
76. Back, S.H.; Kim, Y.K.; Kim, W.J.; Cho, S.; Oh, H.R.; Kim, J.E.; Jang, S.K. Translation of polioviral mRNA is inhibited by cleavage of polypyrimidine tract-binding proteins executed by polioviral 3Cpro. J. Virol. 2002, 76, 2529-2542.
77. McBride, A.E.; Schlegel, A.; Kirkegaard, K. Human protein Sam68 relocalization and interaction with poliovirus RNA polymerase in infected cells. Proc. Natl. Acad. Sci. USA 1996, 93, 2296-2301.
78. Meerovitch, K.; Svitkin, Y.V.; Lee, H.S.; Lejbkowicz, F.; Kenan, D.J.; Chan, E.K.; Agol, V.I.; Keene, J.D.; Sonenberg, N. La autoantigen enhances and corrects aberrant translation of poliovirus RNA in reticulocyte lysate. J. Virol. 1993, 67, 3798-3807.
79. Lidsky, P.V.; Hato, S.; Bardina, M.V.; Aminev, A.G.; Palmenberg, A.C.; Sheval, E.V.; Polyakov, V.Y.; van Kuppeveld, F.J.; Agol, V.I. Nucleocytoplasmic traffic disorder induced by cardioviruses. J. Virol. 2006, 80, 2705-2717.
80. Belov, G.A.; Lidsky, P.V.; Mikitas, O.V.; Egger, D.; Lukyanov, K.A.; Bienz, K.; Agol, V.I. Bidirectional increase in permeability of nuclear envelope upon poliovirus infection and accompanying alterations of nuclear pores. J. Virol. 2004, 78, 10166-10177.
81. Bardina, M.V.; Lidsky, P.V.; Sheval, E.V.; Fominykh, K.V.; van Kuppeveld, F.J.; Polyakov, V.Y.; Agol, V.I. Mengovirus-induced rearrangement of the nuclear pore complex: Hijacking cellular phosphorylation machinery. J. Virol. 2009, 83, 3150-3161.
82. Porter, F.W.; Brown, B.; Palmenberg, A.C. Nucleoporin phosphorylation triggered by the encephalomyocarditis virus leader protein is mediated by mitogen-activated protein kinases. J. Virol. 2010, 84, 12538-12548.
83. Cros, J.F.; Palese, P. Trafficking of viral genomic RNA into and out of the nucleus: Influenza, thogoto and borna disease viruses. Virus Res. 2003, 95, 3-12.
84. Stegmann, T. Membrane fusion mechanisms: The influenza hemagglutinin paradigm and its implications for intracellular fusion. Traffic 2000, 1, 598-604.
85. Watanabe, T.; Watanabe, S.; Kawaoka, Y. Cellular networks involved in the influenza virus life cycle. Cell Host Microbe 2010, 7, 427-439.
86. Chase, G.P.; Rameix-Welti, M.A.; Zvirbliene, A.; Zvirblis, G.; Gotz, V.; Wolff, T.; Naffakh, N.; Schwemmle, M. Influenza virus ribonucleoprotein complexes gain preferential access to cellular export machinery through chromatin targeting. PLoS Pathog. 2011, 7, e1002187.
87. Akarsu, H.; Burmeister, W.P.; Petosa, C.; Petit, I.; Muller, C.W.; Ruigrok, R.W.; Baudin, F. Crystal structure of the M1 protein-binding domain of the influenza A virus nuclear export protein (NEP/NS2). EMBO J. 2003, 22, 4646-4655.
88. O'Neill, R.E.; Talon, J.; Palese, P. The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins. EMBO J. 1998, 17, 288-296.
89. Yasuda, J.; Nakada, S.; Kato, A.; Toyoda, T.; Ishihama, A. Molecular assembly of influenza virus: Association of the NS2 protein with virion matrix. Virology 1993, 196, 249-255.
90. Enninga, J.; Levy, D.E.; Blobel, G.; Fontoura, B.M. Role of nucleoporin induction in releasing an mrna nuclear export block. Science 2002, 295, 1523-1525.
91. Finkelshtein, D.; Werman, A.; Novick, D.; Barak, S.; Rubinstein, M. Ldl receptor and its family members serve as the cellular receptors for vesicular stomatitis virus. Proc. Natl. Acad. Sci. USA 2013, 110, 7306-7311.
92. Schlegel, R.; Willingham, M.C.; Pastan, I.H. Saturable binding sites for vesicular stomatitis virus on the surface of vero cells. J. Virol. 1982, 43, 871-875.
93. Schloemer, R.H.; Wagner, R.R. Cellular adsorption function of the sialoglycoprotein of vesicular stomatitis virus and its neuraminic acid. J. Virol. 1975, 15, 882-893.
94. Lyles, D.S. Cytopathogenesis and inhibition of host gene expression by RNA viruses. Microbiol. Mol. Biol. Rev. 2000, 64, 709-724.
95. Petersen, J.M.; Her, L.S.; Varvel, V.; Lund, E.; Dahlberg, J.E. The matrix protein of vesicular stomatitis virus inhibits nucleocytoplasmic transport when it is in the nucleus and associated with nuclear pore complexes. Mol. Cell Biol. 2000, 20, 8590-8601.
96. Her, L.S.; Lund, E.; Dahlberg, J.E. Inhibition of ran guanosine triphosphatase-dependent nuclear transport by the matrix protein of vesicular stomatitis virus. Science 1997, 276, 1845-1848.
97. Petersen, J.M.; Her, L.S.; Dahlberg, J.E. Multiple vesiculoviral matrix proteins inhibit both nuclear export and import. Proc. Natl. Acad. Sci. USA 2001, 98, 8590-8595.
98. Belov, G.A.; Evstafieva, A.G.; Rubtsov, Y.P.; Mikitas, O.V.; Vartapetian, A.B.; Agol, V.I. Early alteration of nucleocytoplasmic traffic induced by some RNA viruses. Virology 2000, 275, 244-248.
99. Kneller, E.L.P.; Connor, J.H.; Lyles, D.S. HnRNPs relocalize to the cytoplasm following infection with vesicular stomatitis virus. J. Virol. 2009, 83, 770-780.
100. Rajani, K.R.; Kneller, E.L.P.; McKenzie, M.O.; Horita, D.A.; Chou, J.W.; Lyles, D.S. Complexes of vesicular stomatitis virus matrix protein with host Rae1 and Nup98 involved in inhibition of host transcription. PLoS Pathog. 2012, 8, e1002929.
101. Levengood, J.D.; Tolbert, M.; Li, M.L.; Tolbert, B.S. High-affinity interaction of hnrnp A1 with conserved RNA structural elements is required for translation and replication of enterovirus 71. RNA Biol. 2013, 10, 1136-1145.
102. Lin, J.Y.; Shih, S.R.; Pan, M.; Li, C.; Lue, C.F.; Stollar, V.; Li, M.L. Hnrnp A1 interacts with the 5' untranslated regions of enterovirus 71 and sindbis virus rna and is required for viral replication. J. Virol. 2009, 83, 6106-6114.
103. Monette, A.; Ajamian, L.; Lopez-Lastra, M.; Mouland, A.J. Human immunodeficiency virus type 1 (HIV-1) induces the cytoplasmic retention of heterogeneous nuclear ribonucleoprotein A1 by disrupting nuclear import: Implications for HIV-1 gene expression. J. Biol. Chem. 2009, 284, 31350-31362.
104. Stojdl, D.F.; Lichty, B.D.; tenOever, B.R.; Paterson, J.M.; Power, A.T.; Knowles, S.; Marius, R.; Reynard, J.; Poliquin, L.; Atkins, H.; et al. VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell 2003, 4, 263-275.
105. Klasse, P.J. The molecular basis of HIV entry. Cell Microbiol. 2012, 14, 1183-1192.
106. Jayappa, K.D.; Ao, Z.; Yao, X. The HIV-1 passage from cytoplasm to nucleus: The process involving a complex exchange between the components of HIV-1 and cellular machinery to access nucleus and successful integration. Int. J. Biochem. Mol. Biol. 2012, 3, 70-85.
107. Ao, Z.; Huang, G.; Yao, H.; Xu, Z.; Labine, M.; Cochrane, A.W.; Yao, X. Interaction of human immunodeficiency virus type 1 integrase with cellular nuclear import receptor importin 7 and its impact on viral replication. J. Biol. Chem. 2007, 282, 13456-13467.
108. Hearps, A.C.; Jans, D.A. HIV-1 integrase is capable of targeting DNA to the nucleus via an importin α/β-dependent mechanism. Biochem. J. 2006, 398, 475-484.
109. Jayappa, K.D.; Ao, Z.; Yang, M.; Wang, J.; Yao, X. Identification of critical motifs within HIV-1 integrase required for importin α3 interaction and viral cDNA nuclear import. J. Mol. Biol. 2011, 410, 847-862.
110. Jacquot, G.; le Rouzic, E.; David, A.; Mazzolini, J.; Bouchet, J.; Bouaziz, S.; Niedergang, F.; Pancino, G.; Benichou, S. Localization of HIV-1 Vpr to the nuclear envelope: Impact on Vpr functions and virus replication in macrophages. Retrovirology 2007, 4, 84.
111. Le Rouzic, E.; Mousnier, A.; Rustum, C.; Stutz, F.; Hallberg, E.; Dargemont, C.; Benichou, S. Docking of HIV-1 Vpr to the nuclear envelope is mediated by the interaction with the nucleoporin hCG1. J. Biol. Chem. 2002, 277, 45091-45098.
112. Dismuke, D.J.; Aiken, C. Evidence for a functional link between uncoating of the human immunodeficiency virus type 1 core and nuclear import of the viral preintegration complex. J. Virol. 2006, 80, 3712-3720.
113. Yamashita, M.; Emerman, M. Capsid is a dominant determinant of retrovirus infectivity in nondividing cells. J. Virol. 2004, 78, 5670-5678.
114. Chan, E.Y.; Qian, W.J.; Diamond, D.L.; Liu, T.; Gritsenko, M.A.; Monroe, M.E.; Camp, D.G., 2nd; Smith, R.D.; Katze, M.G. Quantitative analysis of human immunodeficiency virus type 1-infected CD4+ cell proteome: Dysregulated cell cycle progression and nuclear transport coincide with robust virus production. J. Virol. 2007, 81, 7571-7583.
115. Chan, E.Y.; Sutton, J.N.; Jacobs, J.M.; Bondarenko, A.; Smith, R.D.; Katze, M.G. Dynamic host energetics and cytoskeletal proteomes in human immunodeficiency virus type 1-infected human primary CD4 cells: Analysis by multiplexed label-free mass spectrometry. J. Virol. 2009, 83, 9283-9295.
116. Navare, A.T.; Sova, P.; Purdy, D.E.; Weiss, J.M.; Wolf-Yadlin, A.; Korth, M.J.; Chang, S.T.; Proll, S.C.; Jahan, T.A.; Krasnoselsky, A. L.; et al. Quantitative proteomic analysis of HIV-1 infected CD4+ T cells reveals an early host response in important biological pathways: Protein synthesis, cell proliferation, and T-cell activation. Virology 2012, 429, 37-46.
117. Zhang, R.; Mehla, R.; Chauhan, A. Perturbation of host nuclear membrane component RanBP2 impairs the nuclear import of human immunodeficiency virus-1 preintegration complex (DNA). PLoS One 2010, 5, e15620.
118. Schaller, T.; Ocwieja, K.E.; Rasaiyaah, J.; Price, A.J.; Brady, T.L.; Roth, S.L.; Hue, S.; Fletcher, A.J.; Lee, K.; KewalRamani, V. N.; et al. HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency. PLoS Pathog. 2011, 7, e1002439.
119. Fricke, T.; Valle-Casuso, J.C.; White, T.E.; Brandariz-Nunez, A.; Bosche, W.J.; Reszka, N.; Gorelick, R.; Diaz-Griffero, F. The ability of TNPO3-depleted cells to inhibit HIV-1 infection requires CPSF6. Retrovirology 2013, 10, doi:10.1186/1742-4690-10-46.
120. Lin, D.H.; Zimmermann, S.; Stuwe, T.; Stuwe, E.; Hoelz, A. Structural and functional analysis of the C-terminal domain of Nup358/RanBP2. J. Mol. Biol. 2013, 425, 1318-1329.
121. Woodward, C.L.; Prakobwanakit, S.; Mosessian, S.; Chow, S.A. Integrase interacts with nucleoporin Nup153 to mediate the nuclear import of human immunodeficiency virus type 1. J. Virol. 2009, 83, 6522-6533.
122. Matreyek, K.A.; Engelman, A. The requirement for nucleoporin Nup153 during human immunodeficiency virus type 1 infection is determined by the viral capsid. J. Virol. 2011, 85, 7818-7827.
123. Monette, A.; Pante, N.; Mouland, A.J. Examining the requirements for nucleoporins by HIV-1. Future Microbiol. 2011, 6, 1247-1250.
124. Ocwieja, K.E.; Brady, T.L.; Ronen, K.; Huegel, A.; Roth, S.L.; Schaller, T.; James, L.C.; Towers, G.J.; Young, J.A.; Chanda, S. K.; et al. HIV integration targeting: A pathway involving transportin-3 and the nuclear pore protein RanBP2. PLoS Pathog. 2011, 7, e1001313.
125. Emerman, M.; Malim, M.H. HIV-1 regulatory/accessory genes: Keys to unraveling viral and host cell biology. Science 1998, 280, 1880-1884.
126. Hofmann, W.; Reichart, B.; Ewald, A.; Muller, E.; Schmitt, I.; Stauber, R.H.; Lottspeich, F.; Jockusch, B.M.; Scheer, U.; Hauber, J.; et al. Cofactor requirements for nuclear export of Rev response element (Rre)-and constitutive transport element (Cte)-containing retroviral rnas. An unexpected role for actin. J. Cell Biol. 2001, 152, 895-910.
127. Ullman, K.S.; Shah, S.; Powers, M.A.; Forbes, D.J. The nucleoporin Nup153 plays a critical role in multiple types of nuclear export. Mol. Biol. Cell 1999, 10, 649-664.
128. Zolotukhin, A.S.; Felber, B.K. Nucleoporins Nup98 and Nup214 participate in nuclear export of human immunodeficiency virus type 1 Rev. J. Virol. 1999, 73, 120-127.
129. Lund, N.; Milev, M.P.; Wong, R.; Sanmuganantham, T.; Woolaway, K.; Chabot, B.; Abou Elela, S.; Mouland, A.J.; Cochrane, A. Differential effects of hnRNP D/AUF1 isoforms on HIV-1 gene expression. Nucleic Acids Res. 2012, 40, 3663-3675.
130. Milev, M.P.; Ravichandran, M.; Khan, M.F.; Schriemer, D.C.; Mouland, A. J. Characterization of staufen1 ribonucleoproteins by mass spectrometry and biochemical analyses reveal the presence of diverse host proteins associated with human immunodeficiency virus type 1. Front Microbiol. 2012, 3, doi:10.3389/fmicb.2012.00367.
131. Huang, H.C.; Chen, C.C.; Chang, W.C.; Tao, M.H.; Huang, C. Entry of hepatitis B virus into immortalized human primary hepatocytes by clathrin-dependent endocytosis. J. Virol. 2012, 86, 9443-9453.
132. Crowther, R.A.; Kiselev, N.A.; Bottcher, B.; Berriman, J.A.; Borisova, G.P.; Ose, V.; Pumpens, P. Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy. Cell 1994, 77, 943-950.
133. Rabe, B.; Glebe, D.; Kann, M. Lipid-mediated introduction of hepatitis B virus capsids into nonsusceptible cells allows highly efficient replication and facilitates the study of early infection events. J. Virol. 2006, 80, 5465-5473.
134. Seeger, C.; Mason, W.S. Hepatitis B virus biology. Microbiol. Mol. Biol. Rev. 2000, 64, 51-68.
135. Kann, M.; Sodeik, B.; Vlachou, A.; Gerlich, W.H.; Helenius, A. Phosphorylation-dependent binding of hepatitis B virus core particles to the nuclear pore complex. J. Cell Biol. 1999, 145, 45-55.
136. Rabe, B.; Vlachou, A.; Pante, N.; Helenius, A.; Kann, M. Nuclear import of hepatitis B virus capsids and release of the viral genome. Proc. Natl. Acad. Sci. USA 2003, 100, 9849-9854.
137. Rabe, B.; Delaleau, M.; Bischof, A.; Foss, M.; Sominskaya, I.; Pumpens, P.; Cazenave, C.; Castroviejo, M.; Kann, M. Nuclear entry of hepatitis B virus capsids involves disintegration to protein dimers followed by nuclear reassociation to capsids. PLoS Pathog. 2009, 5, e1000563.
138. Suzuki, Y.; Craigie, R. The road to chromatin-nuclear entry of retroviruses. Nat. Rev. Microbiol. 2007, 5, 187-196.
139. Bernad, R.; van der Velde, H.; Fornerod, M.; Pickersgill, H. Nup358/RanBP2 attaches to the nuclear pore complex via association with Nup88 and Nup214/CAN and plays a supporting role in CRM1-mediated nuclear protein export. Mol. Cell Biol. 2004, 24, 2373-2384.
140. Moroianu, J. Molecular mechanisms of nuclear protein transport. Crit. Rev. Eukaryot. Gene Expr. 1997, 7, 61-72.
141. Percipalle, P.; Clarkson, W.D.; Kent, H.M.; Rhodes, D.; Stewart, M. Molecular interactions between the importin α/β heterodimer and proteins involved in vertebrate nuclear protein import. J. Mol. Biol. 1997, 266, 722-732.
142. Beaslas, O.; Vihervaara, T.; Li, J.; Laurila, P.P.; Yan, D.; Olkkonen, V.M. Silencing of OSBP-related protein 8 (ORP8) modifies the macrophage transcriptome, nucleoporin p62 distribution, and migration capacity. Exp. Cell Res. 2012, 318, 1933-1945.
143. Strambio-de-Castillia, C.; Niepel, M.; Rout, M.P. The nuclear pore complex: Bridging nuclear transport and gene regulation. Nat. Rev. Mol. Cell Biol. 2010, 11, 490-501.
144. Taylor, K.E.; Mossman, K.L. Recent advances in understanding viral evasion of type 1 interferon. Immunology 2013, 138, 190-197.